Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study

BACKGROUND: Achieving good adherence to self-injected treatments for multiple sclerosis can be difficult. Injection devices may help to overcome some of the injection-related barriers to adherence that can be experienced by patients. We sought to assess short-term adherence to, and tolerability of,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lugaresi, Alessandra, Florio, Ciro, Brescia-Morra, Vincenzo, Cottone, Salvatore, Bellantonio, Paolo, Clerico, Marinella, Centonze, Diego, Uccelli, Antonio, di Ioia, Maria, De Luca, Giovanna, Marcellusi, Andrea, Paolillo, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3368780/
https://www.ncbi.nlm.nih.gov/pubmed/22390218
http://dx.doi.org/10.1186/1471-2377-12-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3368780/
https://www.ncbi.nlm.nih.gov/pubmed/22390218
http://dx.doi.org/10.1186/1471-2377-12-7

Ejemplares similares